Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol 1983;8:1–16.
Ajello L, Georg LK, Steigbigel RT, Wang CJ. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia 1974;66:490–498.
Rinaldi MG. Phaeohyphomycosis. Dermatol Clin 1996;14:147–153.
Matsumoto T, Ajello L, Matsuda T, Szaniszlo PJ, Walsh TJ. Developments in hyalohyphomycosis and phaeohyphomycosis. J Med Vet Mycol 1994;32(Suppl 1):329–349.
Biosafety in microbiological and biomedical laboratories. 4th ed. Washington, DC: US Government Printing Office, 1999:123–124.
De Hoog GS. Significance of fungal evolution for the understanding of their pathogenicity, illustrated with agents of phaeohyphomycosis. Mycoses 1997;40(Suppl 2):5–8.
Sutton DA, Slifkin M, Yakulis R, Rinaldi MG. US case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J Clin Microbiol 1998;36:708–715.
Shelton BG, Kirkland KH, Flanders WD, Morris GK. Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl Environ Microbiol 2002;68:1743–1753.
Jacobson ES. Pathogenic roles for fungal melanins. Clin Microbiol Rev 2000;13:708–717.
Dixon DM, Polak A, Szaniszlo PJ. Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis. J Med Vet Mycol 1987;25:97–106.
Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol 1982;150:1414–1421.
van Duin D, Casadevall A, Nosanchuk JD. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. Antimicrob Agents Chemother 2002;46:3394–3400.
Ikeda R, Sugita T, Jacobson ES, Shinoda T. Effects of melanin upon susceptibility of Cryptococcus to antifungals. Microbiol Immunol 2003;47:271–277.
Revankar SG. Dematiaceous fungi. Semin Respir Crit Care Med 2004;25:183–190.
Bush RK, Prochnau JJ. Alternaria-induced asthma. J Allergy Clin Immunol 2004;113: 227–234.
Bush RK, Portnoy JM, Saxon A, Terr AI, Wood RA. The medical effects of mould exposure. J Allergy Clin Immunol 2006;117:326–333.
Ferguson BJ. Definitions of fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33: 227–235.
Houser SM, Corey JP. Allergic fungal rhinosinusitis: pathophysiology, epidemiology, and diagnosis. Otolaryngol Clin North Am 2000;33:399–409.
Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685–692.
Hamilton BG, Humphreys CW, Conner WC, Hospenthal DR. Allergic bronchopulmonary disease secondary to Bipolaris spicifera: Case report. J Bronchol 2006;13:77–79.
Perez C, Colella MT, Olaizola C, de Capriles CH, Magaldi S, Mata-Essayag S. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia 2005;160:235–238.
Gupta AK, Ryder JE, Baran R, Summerbell RC. Non-dermatophyte onychomycosis. Dermatol Clin 2003;21:257–268.
Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea 2002;21:555–559.
Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004;15:321–327.
Wilhelmus KR, Jones DB. Curvularia keratitis. Trans Am Ophthalmol Soc 2001;99:111–130.
Sutton DA, Rinaldi MG, Kielhofner M. First US report of subcutaneous phaeohyphomycosis caused by Veronaea botryosa in a heart transplant recipient and review of the literature. J Clin Microbiol 2004;42:2843–2846.
Chuan MT, Wu MC. Subcutaneous phaeohyphomycosis caused by Exophiala jeanselmei: successful treatment with itraconazole. Int J Dermatol 1995;34:563–566.
Odell JA, Alvarez S, Cvitkovich DG, Cortese DA, McComb BL. Multiple lung abscesses due to Ochroconis gallopavum, a dematiaceous fungus, in a nonimmunocompromised wood pulp worker. Chest 2000;118:1503–1505.
Yeghen T, Fenelon L, Campbell CK, et al. Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol 1996;49:184–186.
Mazur JE, Judson MA. A case report of a Dactylaria fungal infection in a lung transplant patient. Chest 2001;119:651–653.
Manian FA, Brischetto MJ. Pulmonary infection due to Exophiala jeanselmei: successful treatment with ketoconazole. Clin Infect Dis 1993;16:445–446.
Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004;38:206–216.
Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002;34:467–476.
Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990;23:577–586.
Kuhn FA, Javer AR. Allergic fungal rhinosinusitis: perioperative management, prevention of recurrence, and role of corticosteroid and antifungal agents. Otolaryngol Clin North Am 2000;33:419–433.
Tosti A, Piraccini BM, Lorenzi S, Iorizzo M. Treatment of nondermatophyte mould and Candida onychomycosis. Dermatol Clin 2003;21:491–497.
Thomas PA. Fungal infections of the cornea. Eye 2003;17:852–862.
Summerbell RC, Krajden S, Levine R, Fuksa M. Subcutaneous phaeohyphomycosis caused by Lasiodiplodia theobromae and successfully treated surgically. Med Mycol 2004;42: 543–547.
Kimura M, Goto A, Furuta T, Satou T, Hashimoto S, Nishimura K. Multifocal subcutaneous phaeohyphomycosis caused by Phialophora verrucosa. Arch Pathol Lab Med 2003;127: 91–93.
Clancy CJ, Wingard JR, Hong NM. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000;38:169–175.
Diemert D, Kunimoto D, Sand C, Rennie R. Sputum isolation of Wangiella dermatitidis in patients with cystic fibrosis. Scand J Infect Dis 2001;33:777–779.
Meletiadis J, Mouton JW, Meis JF, Verweij PE. Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans. Clin Microbiol Infect 2000;6:336–337.
Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003;22:111–113.
Suggested Readings
Clancy CJ, Wingard JR, Hong NM. Subcutaneous phaeohyphomycosis in transplant recipients: review of the literature and demonstration of in vitro synergy between antifungal agents. Med Mycol 2000;38:169–175.
Jacobson ES. Pathogenic roles for fungal melanins. Clin Microbiol Rev 2000;13:708–717.
Kuhn FA, Javer AR. Allergic fungal rhinosinusitis: perioperative management, prevention of recurrence, and role of steroids and antifungal agents. Otolaryngol Clin North Am 2000;33:419–433.
Revankar SG, Patterson JE, Sutton DA, Pullen R, Rinaldi MG. Disseminated phaeohyphomycosis: review of an emerging mycosis. Clin Infect Dis 2002;34:467–476.
Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004;38:206–216.
Sharkey PK, Graybill JR, Rinaldi MG, et al. Itraconazole treatment of phaeohyphomycosis. J Am Acad Dermatol 1990;23:577–586.
Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol 2004;15:321–327.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press Inc.
About this chapter
Cite this chapter
Revankar, S.G. (2008). Phaeohyphomycosis—Infection Due to Dark (Dematiaceous) Moulds. In: Hospenthal, D.R., Rinaldi, M.G. (eds) Diagnosis and Treatment of Human Mycoses. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-59745-325-7_11
Download citation
DOI: https://doi.org/10.1007/978-1-59745-325-7_11
Publisher Name: Humana Press
Print ISBN: 978-1-58829-822-5
Online ISBN: 978-1-59745-325-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)